Reporting Requirements Under the Exchange Act. From and after the Option Closing Date, BioMarin shall timely file such information, documents and reports as the Commission may require or prescribe under Section 13 of the Exchange Act. BioMarin acknowledges and agrees that the purposes of the requirements contained in this Section 4.8(e) are to enable Medicis to comply with the current public information requirement contained in paragraph (c) of Rule 144 should Medicis ever wish to dispose of any of the Restricted Stock without registration under the Securities Act in reliance upon Rule 144 (or any other similar exemptive provision).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Biomarin Pharmaceutical Inc), Securities Purchase Agreement (Medicis Pharmaceutical Corp)
Reporting Requirements Under the Exchange Act. From and after the Option Closing Date, BioMarin shall timely file such information, documents and reports as the Commission may require or prescribe under Section 13 of the Exchange Act. BioMarin acknowledges and agrees that the purposes of the requirements contained in this Section 4.8(e) 9.5 are to enable Medicis the Holder to comply with the current public information requirement contained in paragraph (c) of Rule 144 should Medicis the Holder ever wish to dispose of any of the Restricted Stock without registration under the Securities Act in reliance upon Rule 144 (or any other similar exemptive provision).
Appears in 2 contracts
Samples: License Agreement (Biomarin Pharmaceutical Inc), License Agreement (Medicis Pharmaceutical Corp)